Myxedema Coma Following the Administration of Gonadotropin-releasing Hormone Agonist Complicated by Acute Pancreatitis.
Intern Med
; 57(21): 3117-3122, 2018 Nov 01.
Article
em En
| MEDLINE
| ID: mdl-29877268
ABSTRACT
Gonadotropin-releasing hormone (GnRH) agonists have been used for the treatment of various diseases. Although autoimmune thyroid disease has been reported as a rare complication of these agents, the symptoms are almost always transient and non-life-threatening. We herein report a rare case of an 83-year-old man receiving GnRH agonist treatment for prostate cancer who developed myxedema coma complicated by acute pancreatitis. This is the first report of myxedema coma potentially associated with a GnRH agonist. The follow-up of the thyroid function is necessary for patients undergoing treatment with GnRH agonists, especially those known to have or to be susceptible to autoimmune thyroid disease.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Pancreatite
/
Hormônio Liberador de Gonadotropina
/
Leuprolida
/
Coma
/
Antineoplásicos Hormonais
/
Mixedema
Idioma:
En
Ano de publicação:
2018
Tipo de documento:
Article